AIM: To determine characteristics and prognostic predictors of patients with hepatocellular carcinoma (HCC) in association with non-alcoholic fatty liver disease (NAFLD). METHODS: We reviewed the records of all patients with NAFLD associated HCC between 2000 and 2012. Data collected included demographics; histology; presence or absence of cirrhosis, size and number of HCC, alpha-fetoprotein, body mass index (BMI), and the presence of diabetes, hypertension, or dyslipidaemia. RESULTS: Fifty-four patients with NAFLD associated HCC were identified. Mean age was 64 years with 87% male. Fifteen percent (8/54) were not cirrhotic. 11%, 24% and 50% had a BMI of < 25 kg/m2, 25-29 kg/m2 and ≥ 30 kg/m2 respectively. Fifty-nine percent were diabetic...
Hepatocellular carcinoma (HCC) is the sixth most common cancer in world and third largest cause of c...
Obesity and diabetes are associated with the onset of hepatocellular carcinoma (HCC). These two illn...
Hepatocellular cancer (HCC) is the fifth most prevalent cancer worldwide and the third leading cause...
Abstract Background There are limited data regarding the factors associated with hepatocellular carc...
Background. Nonalcoholic fatty liver disease (NAFLD) may develop into liver cirrhosis and hepatocell...
Non-alcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome...
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome ...
Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of liver morbidity worldwide...
Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of liver morbidity worldwide...
Background: Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in...
Hepatocellular carcinoma (HCC) is a cancer with globally rising incidence. Growing evidence supports...
Hepatocellular carcinoma (HCC) is estimated to be the third leading cause of cancer-related mortalit...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide and it...
Worldwide, nonalcoholic fatty liver disease (NAFLD) has reached epidemic proportions and in parallel...
Background: Non-alcoholic fatty liver disease (NAFLD) is a global epidemic involving 20-40% of the g...
Hepatocellular carcinoma (HCC) is the sixth most common cancer in world and third largest cause of c...
Obesity and diabetes are associated with the onset of hepatocellular carcinoma (HCC). These two illn...
Hepatocellular cancer (HCC) is the fifth most prevalent cancer worldwide and the third leading cause...
Abstract Background There are limited data regarding the factors associated with hepatocellular carc...
Background. Nonalcoholic fatty liver disease (NAFLD) may develop into liver cirrhosis and hepatocell...
Non-alcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome...
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome ...
Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of liver morbidity worldwide...
Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of liver morbidity worldwide...
Background: Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in...
Hepatocellular carcinoma (HCC) is a cancer with globally rising incidence. Growing evidence supports...
Hepatocellular carcinoma (HCC) is estimated to be the third leading cause of cancer-related mortalit...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide and it...
Worldwide, nonalcoholic fatty liver disease (NAFLD) has reached epidemic proportions and in parallel...
Background: Non-alcoholic fatty liver disease (NAFLD) is a global epidemic involving 20-40% of the g...
Hepatocellular carcinoma (HCC) is the sixth most common cancer in world and third largest cause of c...
Obesity and diabetes are associated with the onset of hepatocellular carcinoma (HCC). These two illn...
Hepatocellular cancer (HCC) is the fifth most prevalent cancer worldwide and the third leading cause...